Inventor
REISFELD RALPH A
US17 patents
⚠️ This page may combine multiple inventors who share the name “REISFELD RALPH A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCRIPPS RESEARCH INST
10 patentsUS6923958B2Aug 2, 2005
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
SCRIPPS RESEARCH INST58 citations95
US7094410B2Aug 22, 2006
DNA vaccine against proliferating endothelial cells and methods of use thereof
SCRIPPS RESEARCH INST14 citations90
US7365054B2Apr 29, 2008
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
SCRIPPS RESEARCH INST9 citations82
US7279464B2Oct 9, 2007
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
SCRIPPS RESEARCH INST6 citations73
US9655815B2May 23, 2017
DNA vaccines against tumor growth and methods of use thereof
SCRIPPS RESEARCH INST3 citations72
US7569552B2Aug 4, 2009
DNA vaccines against tumor growth and methods of use therof
SCRIPPS RESEARCH INST5 citations71
US10335420B2Jul 2, 2019
Nanoparticle-based tumor-targeted drug delivery
SCRIPPS RESEARCH INST2 citations70
US8053421B2Nov 8, 2011
DNA vaccines against tumor growth and methods of use thereof
SCRIPPS RESEARCH INST3 citations60
US8048428B2Nov 1, 2011
DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
SCRIPPS RESEARCH INST3 citations60
US7833976B2Nov 16, 2010
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
SCRIPPS RESEARCH INST0 citations51
REISFELD RALPH A
3 patentsUS9629922B2Apr 25, 2017
Nanoparticle-based tumor-targeted drug delivery
REISFELD RALPH A1 citations58
US9616137B2Apr 11, 2017
Nanoparticle-based tumor-targeted drug delivery
REISFELD RALPH A1 citations58
US8241637B2Aug 14, 2012
DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
REISFELD RALPH A3 citations58